Artificial intelligence is becoming an increasingly important part of healthcare innovation, influencing how medical information is analysed, clinical decisions are supported, diseases are detected, and healthcare services are delivered. Its applications extend across clinical practice, medical imaging, predictive modelling, precision medicine, digital health, healthcare administration, and biomedical research. At the same time, questions surrounding clinical reliability, data privacy, algorithmic bias, patient safety, transparency, and regulatory governance remain central to its responsible adoption.
The Global Congress on Artificial Intelligence in Healthcare 2027 (GCAIH 2027) is designed to examine these developments through a multidisciplinary academic perspective. Its scientific scope encompasses both technological advancements and their implications for healthcare practice, research, institutional operations, and policy. The congress encourages discussion on the evaluation of AI-based healthcare solutions, evidence-informed implementation, human oversight, and collaboration between medical professionals and technology developers.
Academic and professional relevance
The congress is relevant to medical practitioners, clinicians, healthcare researchers, medical educators, hospital administrators, public health professionals, biomedical engineers, data scientists, AI developers, health-tech companies, and representatives of healthcare institutions. It provides a setting to examine the opportunities and limitations of AI across different healthcare environments and professional disciplines.
Through its scientific programme, GCAIH 2027 seeks to encourage informed academic discussion on the relationship between artificial intelligence, healthcare evidence, professional judgement, and responsible technological innovation.
The Global Congress on Artificial Intelligence in Healthcare 2027 (GCAIH 2027) is organized by WebiConX under a structured academic framework designed to support transparency, professional engagement, and responsible scientific exchange. The congress aims to maintain clear participation guidelines, defined presentation requirements, and an organized approach to academic programme development.
The governance framework emphasizes the relevance and academic quality of submitted contributions, appropriate professional representation, and respectful interdisciplinary discussion. Research abstracts and presentation proposals will be handled in accordance with the congress submission guidelines and applicable review procedures. Participation by speakers, researchers, organizing committee members, and institutional representatives is intended to support a collaborative academic environment.
GCAIH 2027 also recognizes the importance of responsible communication when addressing artificial intelligence in healthcare, particularly in relation to patient safety, data privacy, clinical accountability, algorithmic transparency, and ethical technology adoption. The congress seeks to encourage evidence-informed discussion without replacing established clinical standards, regulatory requirements, or professional judgement.
Congress Theme: Artificial Intelligence in Healthcare: Applications and Future Perspectives
Description:
This session explores how artificial intelligence is supporting clinical decision-making, patient assessment, and care planning across different medical specialties. It will examine AI-assisted clinical workflows, decision-support systems, predictive tools, and the relationship between algorithmic recommendations and professional clinical judgement. Contributions addressing clinical validation, practical implementation, and the impact of AI on patient care are encouraged.
Sub-tracks:
Description:
This session focuses on the application of artificial intelligence in medical imaging and diagnostic interpretation. It will explore machine learning and deep learning approaches used in image analysis, disease detection, diagnostic accuracy, and clinical imaging workflows. Research examining model performance, clinical validation, interoperability, and the limitations of AI-assisted diagnostics is particularly relevant.
Sub-tracks:
Description:
This session examines the role of machine learning, predictive modelling, and advanced analytics in understanding disease patterns and supporting personalised healthcare. It will address the use of clinical, genomic, demographic, and population-level data to predict health risks, identify disease progression, and inform individualised treatment strategies.
Sub-tracks:
Description:
This session explores emerging applications of artificial intelligence in surgical practice, robotic-assisted procedures, and image-guided interventions. It will consider intelligent surgical systems, computer-assisted planning, intraoperative decision support, and technologies designed to improve procedural precision and workflow efficiency. Contributions addressing clinical evaluation, safety, and the practical integration of AI-enabled surgical technologies are welcome.
Sub-tracks:
Description:
This session addresses the integration of artificial intelligence into digital healthcare environments, including telemedicine, connected care platforms, wearable technologies, and remote monitoring systems. It will explore how intelligent digital tools can support continuous health assessment, patient engagement, and care coordination across clinical and community settings.
Sub-tracks:
Description:
This session examines the emerging role of generative artificial intelligence and large language models in healthcare research, clinical documentation, medical education, and professional communication. It will explore opportunities for responsible deployment while addressing accuracy, hallucinations, data protection, explainability, and the need for appropriate human oversight in healthcare applications.
Sub-tracks:
Description:
This session focuses on the use of artificial intelligence across pharmaceutical research, drug discovery, and biomedical innovation. It will explore computational approaches to identifying potential therapeutic targets, predicting molecular properties, supporting drug development, and analysing biomedical datasets. Research addressing translational applications, model validation, and the integration of AI into pharmaceutical workflows is encouraged.
Sub-tracks:
Description:
This session examines how artificial intelligence and data analytics can contribute to public health research, disease surveillance, epidemiological modelling, and population health planning. It will consider the use of predictive systems and large-scale health datasets to identify emerging health trends, assess population-level risks, and support evidence-informed public health interventions.
Sub-tracks:
Description:
This session explores the application of artificial intelligence in healthcare administration, hospital operations, and institutional decision-making. It will examine intelligent resource allocation, patient flow management, operational forecasting, workflow automation, and data-driven approaches to improving healthcare service delivery. Contributions may address implementation challenges, organisational readiness, and measurable operational outcomes.
Sub-tracks:
Description:
This session addresses the ethical, legal, regulatory, and governance considerations associated with artificial intelligence in healthcare. It will examine patient privacy, informed consent, algorithmic bias, transparency, accountability, clinical safety, and regulatory oversight. The session aims to encourage discussion on the principles and institutional practices required for responsible and trustworthy AI adoption.
Sub-tracks:
Description:
This session focuses on the scientific evaluation and real-world implementation of artificial intelligence technologies in healthcare. It will explore research methodologies, clinical validation, model performance assessment, reproducibility, implementation science, and post-deployment monitoring. Contributions examining the gap between AI development and practical healthcare adoption are particularly encouraged.
Sub-tracks:
Description:
This forward-looking session explores emerging technologies and interdisciplinary developments that may shape the future of artificial intelligence in healthcare. It will consider advances in intelligent healthcare systems, multimodal AI, digital twins, federated learning, next-generation clinical technologies, and collaborative innovation. Contributions examining future research priorities, technological opportunities, and pathways for responsible innovation are welcome.
Sub-tracks:
The scientific programme of GCAIH 2027 is supported by an academic organising team committed to interdisciplinary engagement and scientific exchange. Explore the Organising Committee Members contributing to the congress.
The Global Congress on Artificial Intelligence in Healthcare 2027 (GCAIH 2027) offers multiple participation opportunities for professionals, researchers, academicians, students, institutions, and industry representatives. The participation framework is designed to accommodate different levels of academic involvement, professional interests, and contributions to the healthcare AI ecosystem.
Participation in the Global Congress on Artificial Intelligence in Healthcare 2027 (GCAIH 2027) offers opportunities for clinicians, researchers, academicians, students, healthcare professionals, technology specialists, institutions, and industry representatives to engage with emerging developments in healthcare AI.
GCAIH 2027 aims to make participation meaningful across different professional backgrounds by encouraging scientific contribution, knowledge sharing, and collaboration between healthcare, research, academia, and technology communities.
Artificial intelligence is emerging as one of the most significant growth areas within the global healthcare industry. Over the next decade, its commercial potential is expected to expand across medical imaging, clinical decision support, drug discovery, precision medicine, digital health, hospital automation, and healthcare data analytics. This growth is being driven by increasing healthcare technology investment, demand for operational efficiency, advances in generative AI, and the need for more data-driven approaches to patient care.
For GCAIH 2027, the market analysis should distinguish between the AI healthcare market itself and the much larger healthcare industry that AI may influence. The figures below focus on the former.
The global artificial intelligence (AI) in healthcare market was valued at approximately USD 36.7 billion in 2025, according to Grand View Research. Its market forecast estimates growth to approximately USD 505.6 billion by 2033, representing a compound annual growth rate (CAGR) of 38.9% between 2026 and 2033. This expansion reflects increasing investment in AI-powered clinical applications, medical imaging, predictive analytics, healthcare automation, and intelligent decision-support technologies.
Looking towards 2034–2036, market projections indicate the possibility of the global healthcare AI industry reaching several hundred billion dollars and potentially exceeding USD 1 trillion. Fortune Business Insights projects the AI in healthcare market to reach approximately USD 1.03 trillion by 2034, while Grand View Research estimates the broader medical AI market could reach approximately USD 1.05 trillion by 2036. These are separate market estimates using different definitions and research methodologies, rather than a single agreed industry forecast.
This growth is expected to create substantial commercial and research opportunities across medical diagnostics, AI-assisted surgery, drug discovery, precision medicine, generative AI, digital health, remote patient monitoring, and hospital management. Healthcare providers, pharmaceutical companies, medical technology developers, universities, research institutions, and AI solution providers are all positioned to participate in this expanding ecosystem.
For GCAIH 2027, this projected market expansion highlights the importance of bringing together the healthcare and technology communities. The congress provides an academic platform to examine emerging applications, present research, discuss implementation challenges, and explore the scientific, ethical, and institutional considerations shaping the next decade of AI-enabled healthcare.
Market outlook: The healthcare AI sector is moving towards a potential trillion-dollar industry over the next decade, although actual growth will depend on technology adoption, clinical validation, investment, regulatory developments, and the ability to demonstrate measurable value in healthcare.
Market estimates are third-party forecasts, not guaranteed outcomes. The AI in healthcare market and the broader medical AI market have overlapping but different scopes.
The Young Researcher Forum (YRF) at the Global Congress on Artificial Intelligence in Healthcare 2027 (GCAIH 2027) is designed to encourage the participation of emerging researchers, postgraduate students, doctoral candidates, and early-career professionals working in artificial intelligence, healthcare, biomedical sciences, and related disciplines.
The forum provides an academic environment for young investigators to present their research, share innovative ideas, receive feedback, and engage with experienced researchers and professionals. It aims to support early-stage research development, scientific communication, interdisciplinary learning, and professional networking within the healthcare AI community.
The Young Researcher Forum is open to:
Eligible research contributions may include:
Participation note: Applicants should submit their research contributions in accordance with the congress abstract submission guidelines. Eligibility for the forum and any awards, certificates, or recognition will be subject to the final programme guidelines announced by the organising committee.